Changes

Jump to navigation Jump to search
926 bytes removed ,  16:52, 26 August 2010
Line 45: Line 45:  
Histologic changes are non-specific but include acanthosis, a mixed mononuclear perivascular dermatitis, sebaceous gland metaplasia and secondary superficial pyoderma<sup>1</sup>.
 
Histologic changes are non-specific but include acanthosis, a mixed mononuclear perivascular dermatitis, sebaceous gland metaplasia and secondary superficial pyoderma<sup>1</sup>.
   −
== Treatment ==
+
==Treatment==
 +
 
 +
===Flare factors===
 +
====Ectoparasites====
   −
Flare factors
  −
Ectoparasites
   
Fleas and Neotrombicula frequently complicate
 
Fleas and Neotrombicula frequently complicate
 
AD. Atopic dogs can also contract Sarcoptes.
 
AD. Atopic dogs can also contract Sarcoptes.
Line 62: Line 63:  
pyoderma, however, can benefit from long term
 
pyoderma, however, can benefit from long term
 
pulse antibiotic therapy.
 
pulse antibiotic therapy.
Stress
+
 
 +
====Stress====
 
Stress can exacerbate human inflammatory dermatoses,
 
Stress can exacerbate human inflammatory dermatoses,
 
and this may be true in animals. There is
 
and this may be true in animals. There is
 
anecdotal evidence that behavioral therapy and
 
anecdotal evidence that behavioral therapy and
 
pheromones can help.
 
pheromones can help.
Environmental effects
+
 
 +
====Environmental effects====
 
Excesses of temperature and humidity, irritant
 
Excesses of temperature and humidity, irritant
 
surfaces or cleaning solutions etc. can all worsen
 
surfaces or cleaning solutions etc. can all worsen
 
skin diseases. Observant owners will often report
 
skin diseases. Observant owners will often report
 
associations.
 
associations.
Improving skin barrier function
+
 
Diet and the skin
+
===Improving skin barrier function===
 +
 
 +
====Diet and the skin====
 
Many atopic animals non-specifically improve
 
Many atopic animals non-specifically improve
 
following food trials, probably because high quality,
 
following food trials, probably because high quality,
Line 94: Line 99:  
Support diets significantly ameliorated clinical
 
Support diets significantly ameliorated clinical
 
signs in atopic dogs.
 
signs in atopic dogs.
Topical therapy
+
 
 +
====Topical therapy====
 
Topical therapy has a number of benefits although
 
Topical therapy has a number of benefits although
 
it is time-consuming. Physical removal of allergens
 
it is time-consuming. Physical removal of allergens
Line 114: Line 120:  
prepared to try different products and/or alternate
 
prepared to try different products and/or alternate
 
between antimicrobial and emollient shampoos.
 
between antimicrobial and emollient shampoos.
Essential fatty acids (EFA)
+
 
 +
====Essential fatty acids (EFA)====
 
Numerous clinical trials and studies have evaluated
 
Numerous clinical trials and studies have evaluated
 
EFAs particularly the n-3 EFA eicosapentenoic acid
 
EFAs particularly the n-3 EFA eicosapentenoic acid
Line 135: Line 142:  
much of this is due to anti-inflammatory activity
 
much of this is due to anti-inflammatory activity
 
or cutaneous barrier improvements is unclear (4).
 
or cutaneous barrier improvements is unclear (4).
Allergen specific therapy
+
 
 +
===Allergen specific therapy===
 
Allergen specific therapy will only be appropriate
 
Allergen specific therapy will only be appropriate
 
in animals with identified sensitivities. The aim of
 
in animals with identified sensitivities. The aim of
 
allergen testing is to identify allergens for avoidance
 
allergen testing is to identify allergens for avoidance
 
and immunotherapy, not to confirm the diagnosis.
 
and immunotherapy, not to confirm the diagnosis.
Allergen avoidance
+
 
 +
====Allergen avoidance====
 
Allergen avoidance measures can result in a significant
 
Allergen avoidance measures can result in a significant
 
reduction in exposure to house dust mite (5).
 
reduction in exposure to house dust mite (5).
Line 146: Line 155:  
significant improvement is controversial, although
 
significant improvement is controversial, although
 
one uncontrolled study demonstrated that allergen
 
one uncontrolled study demonstrated that allergen
avoidance was beneficial in canine AD (6). Allergen specific immunotherapy (ASIT)
+
avoidance was beneficial in canine AD (6).  
 +
 
 +
====Allergen specific immunotherapy (ASIT)====
 
ASIT involves the administration of gradually
 
ASIT involves the administration of gradually
 
increasing amounts of allergen by subcutaneous
 
increasing amounts of allergen by subcutaneous
Line 207: Line 218:  
too high although mild reactions can sometimes be
 
too high although mild reactions can sometimes be
 
managed with antihistamines.
 
managed with antihistamines.
Anti-inflammatory therapy
+
 
 +
===Anti-inflammatory therapy===
 
Anti-inflammatory therapy is used as required
 
Anti-inflammatory therapy is used as required
 
to control residual pruritus and inflammation.
 
to control residual pruritus and inflammation.
Line 214: Line 226:  
and/or potency of drugs can be reduced if other
 
and/or potency of drugs can be reduced if other
 
treatments are successful in the long term.
 
treatments are successful in the long term.
Cyclosporine
+
 
 +
====Cyclosporine====
 
Cyclosporine suppresses T-cells, which have been
 
Cyclosporine suppresses T-cells, which have been
 
implicated in the pathogenesis of canine AD.
 
implicated in the pathogenesis of canine AD.
Line 290: Line 303:  
pros and cons for each individual case should
 
pros and cons for each individual case should
 
be discussed with the owner.
 
be discussed with the owner.
Tacrolimus
+
 
Tacrolimus has a similar mechanism of action to
+
====Phytopica™====
cyclosporine. A 0.1% tacrolimus ointment lead
  −
to a greater than 50% improvement in 70-75% of
  −
atopic dogs with localized lesions in two trials
  −
(12,13). Plasma levels remained low throughout
  −
and no adverse effects apart from minor self
  −
trauma immediately after application were seen.
  −
Phytopica™
   
Phytopica™, a compound derived from Rehmannia
 
Phytopica™, a compound derived from Rehmannia
 
glutinosa, Paeonia lactiflora and Glycyrrhiza
 
glutinosa, Paeonia lactiflora and Glycyrrhiza
Line 314: Line 320:  
safety profile than has been reported for other
 
safety profile than has been reported for other
 
anti-inflammatory therapies (16).
 
anti-inflammatory therapies (16).
Glucocorticoids
+
 
 +
====Glucocorticoids====
 
Corticosteroids, synthesized in the adrenal cortex,
 
Corticosteroids, synthesized in the adrenal cortex,
 
have glucocorticoid (anti-inflammatory and
 
have glucocorticoid (anti-inflammatory and
Line 430: Line 437:  
clinical signs if cyclosporine has to be withdrawn
 
clinical signs if cyclosporine has to be withdrawn
 
because of routine vaccination.
 
because of routine vaccination.
Hydrocortisone aceponate
+
 
 +
====Hydrocortisone aceponate====
 
Hydrocortisone aceponate is a novel topical
 
Hydrocortisone aceponate is a novel topical
 
diester glucocorticoid for the treatment of pruritus
 
diester glucocorticoid for the treatment of pruritus
Line 466: Line 474:  
other day therapy. Twice weekly administration,
 
other day therapy. Twice weekly administration,
 
however, resulted in a relapse in most dogs.
 
however, resulted in a relapse in most dogs.
Antihistamines
+
 
 +
====Antihistamines====
 
A large review of clinical trials (16) concluded
 
A large review of clinical trials (16) concluded
 
that there is no more than fair evidence of
 
that there is no more than fair evidence of
Line 480: Line 489:  
are more common and include gastrointestinal
 
are more common and include gastrointestinal
 
tract upsets and cardiac arrhythmias.
 
tract upsets and cardiac arrhythmias.
Other therapeutic options
  −
Phosphodiesterase inhibitors improve peripheral
  −
blood flow and oxygenation, and are immunomodulating.
  −
There is fair evidence for medium
  −
efficacy of pentoxifylline (10 mg/kg 2-3 times
  −
daily) and medium to high efficacy of arofylline
  −
(1 mg/kg twice daily) (16). Arofylline caused
  −
frequent vomiting, but no adverse effects were
  −
seen with pentoxifylline.
  −
Misoprostol is a prostaglandin E1 analogue that
  −
inhibits activation of basophils, mast cells and
  −
eosinophils, blunting late-phase inflammatory
  −
reactions. Two studies have provided fair evidence
  −
of medium efficacy in canine AD at 6-10 μg/kg
  −
three times daily (16). Misoprostol was well
  −
tolerated with only minor gastrointestinal tract
  −
signs reported.
      
==Prognosis==
 
==Prognosis==
6,502

edits

Navigation menu